Sequenom Discloses Test Data Mishandled; Shares Plunge - Xconomy

Sequenom Discloses Test Data Mishandled; Shares Plunge
Xconomy, MA
SEQureDx is intended to test a pregnant mother's blood sample. But the company did not explain how research and development data for SEQureDx was mishandled. “All I can really say is that during a management review of the data we discovered ...
Sequenom (Nasdaq: SQNM) Bombshell istockAnalyst.com (press release)
all 26 news articles

Source: xconomy.com